P2RY14
MOLECULAR TARGETpurinergic receptor P2Y14
P2RY14 (purinergic receptor P2Y14) is targeted by 5 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting P2RY14
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | pptn | 2.89 | 17 |
| 2 | Uridine Diphosphate | 2.20 | 8 |
| 3 | Uridine Diphosphate Glucose | 2.08 | 7 |
| 4 | Uridine Diphosphate Galactose | 1.79 | 5 |
| 5 | Uridine Diphosphate Glucuronic Acid | 1.79 | 5 |
About P2RY14 as a Drug Target
P2RY14 (purinergic receptor P2Y14) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 5 compounds with documented P2RY14 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
P2RY14 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.